IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 117 filers reported holding IMMUNOVANT INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,141,185 | +589.7% | 602,792 | +240.8% | 0.00% | – |
| Q2 2023 | $3,355,035 | -47.2% | 176,860 | -56.8% | 0.00% | -100.0% |
| Q1 2023 | $6,356,216 | +52.5% | 409,814 | +74.5% | 0.00% | – |
| Q4 2022 | $4,167,754 | +2835.0% | 234,803 | +821.8% | 0.00% | – |
| Q3 2022 | $142,000 | +153.6% | 25,472 | +76.6% | 0.00% | – |
| Q2 2022 | $56,000 | -61.1% | 14,424 | -44.9% | 0.00% | – |
| Q1 2022 | $144,000 | -92.5% | 26,167 | -88.4% | 0.00% | – |
| Q4 2021 | $1,921,000 | +132.0% | 225,448 | +136.6% | 0.00% | – |
| Q3 2021 | $828,000 | -41.9% | 95,306 | -29.3% | 0.00% | – |
| Q2 2021 | $1,425,000 | -28.5% | 134,721 | +8.4% | 0.00% | – |
| Q1 2021 | $1,993,000 | +60.7% | 124,293 | +362.6% | 0.00% | – |
| Q4 2020 | $1,240,000 | +5.3% | 26,868 | -19.7% | 0.00% | – |
| Q3 2020 | $1,178,000 | +303.4% | 33,450 | +178.8% | 0.00% | – |
| Q2 2020 | $292,000 | +122.9% | 11,997 | +42.6% | 0.00% | – |
| Q1 2020 | $131,000 | – | 8,412 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |